StuffThatWorks
StuffThatWorks is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at StuffThatWorks.
StuffThatWorks is a company.
Key people at StuffThatWorks.
StuffThatWorks is a healthcare technology company that builds a crowdsourced platform leveraging machine learning and AI to create a knowledge database of patient-reported outcomes for chronic condition treatments.[1][2][3][5] It serves individuals with chronic illnesses by providing personalized insights into treatment efficacy, helping users identify what works best based on real-world data from peers, with the platform improving as more patients contribute structured experiences.[1][3][5] The company solves the problem of fragmented, anecdotal health information by organizing patient stories into analyzable data, enabling AI-driven discoveries like new uses for existing drugs in underserved populations.[1]
Founded in 2018 and headquartered in Tel Aviv, Israel, StuffThatWorks has raised $25 million in Series A funding, employs 11-50 people, and carries an enterprise value of $100-150 million, reflecting strong growth momentum including revenue increases of 136% in 2020 and 100% in 2021.[2][4]
StuffThatWorks was founded in 2018 by Yael (full name not specified in sources), emerging from a focus on addressing gaps in chronic disease management through patient-generated data.[1][4] The idea stemmed from recognizing that patients' real-world experiences with treatments were underutilized, leading to the creation of a platform that structures this information consistently across conditions for AI analysis.[1][5] Early traction came from building a scalable data foundation, with investors like Bessemer Venture Partners backing a $25 million Series A round, signaling validation of its crowdsourcing model.[2][3] Key moments include rapid revenue growth post-launch and expansion to cover multiple chronic conditions, positioning it as a leader in patient-reported outcomes.[2]
StuffThatWorks rides the wave of real-world evidence (RWE) in healthcare, where patient-reported outcomes complement clinical trials amid rising chronic disease prevalence and demand for personalized medicine.[1][5] Its timing aligns with AI advancements in health data analysis and post-pandemic emphasis on digital health tools, amplified by market forces like regulatory pushes for RWE (e.g., FDA guidelines) and investor interest in healthtech unicorns.[2][3] By influencing the ecosystem, it provides pharma and researchers with actionable insights, potentially accelerating drug repurposing and reducing development costs, while fostering a community-driven shift from clinician-led to patient-empowered care.[1]
StuffThatWorks is poised for expansion through deeper AI enhancements and partnerships with pharma giants seeking RWE datasets, potentially scaling to global coverage of more conditions.[1][2] Trends like generative AI for health predictions and decentralized clinical trials will shape its trajectory, boosting data volume and monetization via B2B licensing.[5] Its influence may evolve from a patient tool to an industry-standard database, solidifying its role in transforming chronic care—much like how it started by turning scattered stories into structured, lifesaving knowledge.[3]
Key people at StuffThatWorks.
